162 related articles for article (PubMed ID: 38054408)
1. Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group.
Schmidt RJ; Steeves M; Bayrak-Toydemir P; Benson KA; Coe BP; Conlin LK; Ganapathi M; Garcia J; Gollob MH; Jobanputra V; Luo M; Ma D; Maston G; McGoldrick K; Palculict TB; Pesaran T; Pollin TI; Qian E; Rehm HL; Riggs ER; Schilit SLP; Sergouniotis PI; Tvrdik T; Watkins N; Zec L; Zhang W; Lebo MS;
Genet Med; 2024 Mar; 26(3):101036. PubMed ID: 38054408
[TBL] [Abstract][Full Text] [Related]
2. Considerations for clinical curation, classification, and reporting of low-penetrance and low effect size variants associated with disease risk.
Senol-Cosar O; Schmidt RJ; Qian E; Hoskinson D; Mason-Suares H; Funke B; Lebo MS
Genet Med; 2019 Dec; 21(12):2765-2773. PubMed ID: 31147632
[TBL] [Abstract][Full Text] [Related]
3. Somatic cancer variant curation and harmonization through consensus minimum variant level data.
Ritter DI; Roychowdhury S; Roy A; Rao S; Landrum MJ; Sonkin D; Shekar M; Davis CF; Hart RK; Micheel C; Weaver M; Van Allen EM; Parsons DW; McLeod HL; Watson MS; Plon SE; Kulkarni S; Madhavan S;
Genome Med; 2016 Nov; 8(1):117. PubMed ID: 27814769
[TBL] [Abstract][Full Text] [Related]
4. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards.
Danos AM; Ritter DI; Wagner AH; Krysiak K; Sonkin D; Micheel C; McCoy M; Rao S; Raca G; Boca SM; Roy A; Barnell EK; McMichael JF; Kiwala S; Coffman AC; Kujan L; Kulkarni S; Griffith M; Madhavan S; Griffith OL;
Hum Mutat; 2018 Nov; 39(11):1721-1732. PubMed ID: 30311370
[TBL] [Abstract][Full Text] [Related]
5. Clinical Interpretation of Sequence Variants.
Zhang J; Yao Y; He H; Shen J
Curr Protoc Hum Genet; 2020 Jun; 106(1):e98. PubMed ID: 32176464
[TBL] [Abstract][Full Text] [Related]
6. Specifications of the ACMG/AMP variant curation guidelines for myocilin: Recommendations from the clingen glaucoma expert panel.
Burdon KP; Graham P; Hadler J; Hulleman JD; Pasutto F; Boese EA; Craig JE; Fingert JH; Hewitt AW; Siggs OM; Whisenhunt K; Young TL; Mackey DA; Dubowsky A; Souzeau E
Hum Mutat; 2022 Dec; 43(12):2170-2186. PubMed ID: 36217948
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification.
Chora JR; Iacocca MA; Tichý L; Wand H; Kurtz CL; Zimmermann H; Leon A; Williams M; Humphries SE; Hooper AJ; Trinder M; Brunham LR; Costa Pereira A; Jannes CE; Chen M; Chonis J; Wang J; Kim S; Johnston T; Soucek P; Kramarek M; Leigh SE; Carrié A; Sijbrands EJ; Hegele RA; Freiberger T; Knowles JW; Bourbon M;
Genet Med; 2022 Feb; 24(2):293-306. PubMed ID: 34906454
[TBL] [Abstract][Full Text] [Related]
8. Toward robust clinical genome interpretation: Developing a consistent terminology to characterize Mendelian disease-gene relationships-allelic requirement, inheritance modes, and disease mechanisms.
Roberts AM; DiStefano MT; Riggs ER; Josephs KS; Alkuraya FS; Amberger J; Amin M; Berg JS; Cunningham F; Eilbeck K; Firth HV; Foreman J; Hamosh A; Hay E; Leigh S; Martin CL; McDonagh EM; Perrett D; Ramos EM; Robinson PN; Rath A; Sant DW; Stark Z; Whiffin N; Rehm HL; Ware JS
Genet Med; 2024 Feb; 26(2):101029. PubMed ID: 37982373
[TBL] [Abstract][Full Text] [Related]
9. Evaluating ClinGen variant curation expert panels' application of PVS1 code.
Wang X; Li H; Luo H; Zou Y; Li H; Qin Y; Song J
Eur J Med Genet; 2024 Feb; 67():104909. PubMed ID: 38199457
[TBL] [Abstract][Full Text] [Related]
10. Variant Classification for Pompe disease; ACMG/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel.
Goldstein JL; McGlaughon J; Kanavy D; Goomber S; Pan Y; Deml B; Donti T; Kearns L; Seifert BA; Schachter M; Son RG; Thaxton C; Udani R; Bali D; Baudet H; Caggana M; Hung C; Kyriakopoulou L; Rosenblum L; Steiner R; Pinto E Vairo F; Wang Y; Watson M; Fernandez R; Weaver M; Clarke L; Rehder C
Mol Genet Metab; 2023; 140(1-2):107715. PubMed ID: 37907381
[TBL] [Abstract][Full Text] [Related]
11. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak P; Griffith M; Danos AM; Pitel BA; Madhavan S; Liu X; Chow C; Williams H; Carmody L; Barrow-Laing L; Rieke D; Kreutzfeldt S; Stenzinger A; Tamborero D; Benary M; Rajagopal PS; Ida CM; Lesmana H; Satgunaseelan L; Merker JD; Tolstorukov MY; Campregher PV; Warner JL; Rao S; Natesan M; Shen H; Venstrom J; Roy S; Tao K; Kanagal-Shamanna R; Xu X; Ritter DI; Pagel K; Krysiak K; Dubuc A; Akkari YM; Li XS; Lee J; King I; Raca G; Wagner AH; Li MM; Plon SE; Kulkarni S; Griffith OL; Chakravarty D; Sonkin D
Genet Med; 2022 May; 24(5):986-998. PubMed ID: 35101336
[TBL] [Abstract][Full Text] [Related]
12. Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.
Spier I; Yin X; Richardson M; Pineda M; Laner A; Ritter D; Boyle J; Mur P; Hansen TVO; Shi X; Mahmood K; Plazzer JP; Ognedal E; Nordling M; Farrington SM; Yamamoto G; Baert-Desurmont S; Martins A; Borras E; Tops C; Webb E; Beshay V; Genuardi M; Pesaran T; Capellá G; Tavtigian SV; Latchford A; Frayling IM; Plon SE; Greenblatt M; Macrae FA; Aretz S;
Genet Med; 2024 Feb; 26(2):100992. PubMed ID: 37800450
[TBL] [Abstract][Full Text] [Related]
13. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.
Kobayashi Y; Yang S; Nykamp K; Garcia J; Lincoln SE; Topper SE
Genome Med; 2017 Feb; 9(1):13. PubMed ID: 28166811
[TBL] [Abstract][Full Text] [Related]
15. ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.
Gelb BD; Cavé H; Dillon MW; Gripp KW; Lee JA; Mason-Suares H; Rauen KA; Williams B; Zenker M; Vincent LM;
Genet Med; 2018 Nov; 20(11):1334-1345. PubMed ID: 29493581
[TBL] [Abstract][Full Text] [Related]
16. A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen).
Ritter DI; Rao S; Kulkarni S; Madhavan S; Offit K; Plon SE
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645350
[TBL] [Abstract][Full Text] [Related]
17. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup.
Walker LC; Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison SM; Spurdle AB;
Am J Hum Genet; 2023 Jul; 110(7):1046-1067. PubMed ID: 37352859
[TBL] [Abstract][Full Text] [Related]
18. ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease.
Wallace DF; Dooley JS
Hum Genet; 2020 Aug; 139(8):1065-1075. PubMed ID: 32248359
[TBL] [Abstract][Full Text] [Related]
19. ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
Rivera-Muñoz EA; Milko LV; Harrison SM; Azzariti DR; Kurtz CL; Lee K; Mester JL; Weaver MA; Currey E; Craigen W; Eng C; Funke B; Hegde M; Hershberger RE; Mao R; Steiner RD; Vincent LM; Martin CL; Plon SE; Ramos E; Rehm HL; Watson M; Berg JS
Hum Mutat; 2018 Nov; 39(11):1614-1622. PubMed ID: 30311389
[TBL] [Abstract][Full Text] [Related]
20. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
Box NF; Duffy DL; Chen W; Stark M; Martin NG; Sturm RA; Hayward NK
Am J Hum Genet; 2001 Oct; 69(4):765-73. PubMed ID: 11500805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
